Ozketen Ahmet Caglar, Kazan Hasan Huseyin, Özverel Cenk Serhan, Şanlıdağ Tamer
DESAM Research Institute Near East University, Nicosia, Cyprus.
Department of Medical Genetics Faculty of Medicine Near East University, Nicosia, Cyprus.
Transbound Emerg Dis. 2024 Oct 1;2024:8398470. doi: 10.1155/2024/8398470. eCollection 2024.
Since the pandemic in 2019, coronaviruses (CoVs) have been a great concern for public health burden. The fact that CoVs can infect all animals including domestic ones and livestock points to a future pandemic even though interaction between human and wildlife animals is restricted. Moreover, interspecies transmission abilities of CoVs by mutations make them drastically risky not only for humans but also for animal health. Recently, a new CoV outbreak in cats in Cyprus, the so-called FCoV-23, has been realized. In addition to worries over animal health, any possible transmission to humans is now controversial. However, there have been limited characterization studies on FCoV-23. Thus, we aimed to assess the possible transmission of FCoV-23 to humans using prediction tools. Accordingly, we first checked the binding affinities of receptor binding domain (RBD) of FCoV-23 against feline target protein and its human homolog. Next, we randomly and rationally created mutations on the RBD sequence and evaluated the binding affinities using protein docking tools. Our results underlined that multiple mutations at the same time were needed for increased binding affinity towards human target protein, demonstrating that the probability of transmission to humans was extremely low when mutation rates were regarded. Still, further molecular studies are required to comprehensively conclude the possible transmission risk.
自2019年大流行以来,冠状病毒一直是公共卫生负担的重大关注点。尽管人类与野生动物的接触受到限制,但冠状病毒能够感染包括家畜和牲畜在内的所有动物这一事实预示着未来可能会发生大流行。此外,冠状病毒通过突变产生的跨物种传播能力使其不仅对人类,而且对动物健康都具有极大风险。最近,塞浦路斯出现了一种新的猫冠状病毒疫情,即所谓的FCoV-23。除了对动物健康的担忧外,现在对于其是否可能传播给人类也存在争议。然而,针对FCoV-23的特征研究有限。因此,我们旨在使用预测工具评估FCoV-23向人类传播的可能性。相应地,我们首先检查了FCoV-23受体结合域(RBD)与猫科动物靶蛋白及其人类同源物的结合亲和力。接下来,我们在RBD序列上随机且合理地引入突变,并使用蛋白质对接工具评估结合亲和力。我们的结果强调,需要同时发生多个突变才能增加对人类靶蛋白的结合亲和力,这表明考虑到突变率,其传播给人类的可能性极低。尽管如此,仍需要进一步的分子研究来全面确定可能的传播风险。